# A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

> **NCT07073820** · PHASE2 · RECRUITING · sponsor: **Pfizer** · enrollment: 36 (estimated)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** PF-07868489

## Key facts

- **NCT ID:** NCT07073820
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-10
- **Primary completion:** 2028-07-18
- **Final completion:** 2028-07-18
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07073820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07073820, "A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT07073820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*